Eraxis (anidulafungin) for serious Candida fungal infections

Pfizer will be promoting Eraxis (anidulafungin) for serious Candida fungal infections.

It's similar to Cancidas (caspofungin) and Mycamine (micafungin). These "candins" inhibit formation of the fungal cell wall.

Eraxis is given IV. It will be used for Candida infections in the bloodstream. It's more effective than fluconazole.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote